✦ LIBER ✦

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

✍ Scribed by Jaime Coronel; Lucely Cetina; Irlanda Pacheco; Catalina Trejo-Becerril; Aurora González-Fierro; Erick de la Cruz-Hernandez; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Daymi Arias-Bofill; Myrna Candelaria; Silvia Vidal; Alfonso Dueñas-González

Book ID: 107577314
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 210 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9700-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III randomized double blind placeb

Phase III randomized double blind placebo controlled trial of carboplatin and radiation therapy ± amifostine in patients with head and neck cancer

✍ J. Buentzel; A. Monnier; J. Ammon; G. Schmitt; N. Willich; L. Hammershaimb; G. A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 20 KB

Photodynamic therapy with BF-200 ALA for

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

✍ R.-M. Szeimies; P. Radny; M. Sebastian; F. Borrosch; T. Dirschka; G. Krähn-Senft 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Rituximab for rheumatoid arthritis refra

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

✍ Stanley B. Cohen; Paul Emery; Maria W. Greenwald; Maxime Dougados; Richard A. Fu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 3 views

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views